Jin-lai Wei
发表
Z. Fu,
Weidong Lu,
Hao Wang,
2014,
Cancer letters.
Z. Fu,
Weidong Lu,
Jin-lai Wei,
2016,
Technology in cancer research & treatment.
Jin-lai Wei,
Jinlan Hou,
Yu-Meng Chen,
2022,
Pharmaceutical biology.
Jianguo Yang,
Yajun Luo,
Siqi Huang,
2022,
Clinical and translational medicine.
He Zhou,
Jianguo Yang,
Yajun Luo,
2021,
Cell Death & Disease.
xiangru zheng,
Z. Fu,
Xiaoli Li,
2021,
Cancer cell international.
PRRX1 promotes epithelial–mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer
Z. Fu,
Weidong Lu,
Jihong Feng,
2014,
Medical Oncology.
Rong Wang,
Xing-ye Wu,
Yongfu Xiong,
2017,
Oncotarget.
Z. Fu,
Xiaoli Li,
Wen-jun Li,
2020,
Aging.
Rong Wang,
Xing-ye Wu,
Yongfu Xiong,
2016,
Oncotarget.
H. Yang,
Rong Wang,
Yongfu Xiong,
2017,
Journal of Translational Medicine.
Min Fang,
Z. Fu,
Jin-lai Wei,
2015,
Oncology reports.
Hao Wang,
Z. Fu,
Weidong Lu,
2014,
Molecular and Cellular Biochemistry.
Min Fang,
Hao Wang,
Z. Fu,
2014,
Tumor Biology.
Z. Fu,
Jin-lai Wei,
Jinbao Guo,
2014,
Medical Oncology.
Rong Wang,
Hua Yang,
Yongfu Xiong,
2017,
Journal of Translational Medicine.
Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancer
Min Fang,
Rong Wang,
Z. Fu,
2017,
Oncotarget.
Guo-Jun Chen,
Xue-feng Wang,
Jing Luo,
2014,
Molecular Neurobiology.
Z. Fu,
Weidong Lu,
Jin-lai Wei,
2016,
Technology in cancer research & treatment.